Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial
The CRYSTAL Study: Cryodevitalization Study for the Treatment of Early-Stage Lung Cancer
Vanderbilt-Ingram Cancer Center
30 participants
Sep 27, 2024
INTERVENTIONAL
Conditions
Summary
This clinical trial studies side effects and best treatment time of cryodevitalization in treating patients with early stage (stage I or stage II) lung cancer. Cryodevitalization is a type of cryosurgery that uses a flexible probe (cryoprobe) to kill tumor cells by freezing them. It is delivered at the time of standard diagnostic robotic bronchoscopy. Using cryodevitalization may be safe, tolerable and/or effective in treating patients with early stage lung cancer.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Undergo cryodevitalization
Undergo standard of care robotic bronchoscopy with biopsy
Undergo standard of care robotic bronchoscopy with biopsy
Undergo standard of care surgical resection
Undergo chest x-ray
Undergo Computed Tomography
Undergo tissue sample collection
Ancillary studies
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06593106